Grail’s Cancer Blood Test Nears Landmark FDA Approval, but Insurance Coverage Looms

Galleri cancer blood test nears landmark US approval

No such test is FDA-approved, and US private insurers and government health programs, including Medicare, generally do not...

FDA panel endorses first-of-its-kind cancer blood test

Grail Inc.’s Galleri test doesn’t diagnose cancer but instead, with a single blood draw, looks for a signal that someone might have one of a long list of tumors.

Grail’s cancer blood test nears landmark FDA approval, but insurance coverage looms

By Sneha S K and Kamal Choudhury Oct 2 (Reuters) - An advisory panel to the US Food and Drug Administration handed Grail's Galleri blood test a milestone win last week, saying the early cancer detection test's potential benefits outweigh its risks and...

A Cancer Test Has Investors Betting Big. But Will Insurers Pay?

An FDA panel backed Grail’s Galleri test. But the Medicare money the business depends on is far from guaranteed.